Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.

Guiomar R, Pereira da Silva S, Conde P, Cristóvão P, Maia AC, Pechirra P, Rodrigues AP, Nunes B; Portuguese Laboratory Network for the Diagnosis of Influenza Infection, Milho L, Coelho AP, Fernandes A, Caseiro P, Rodrigues F, Correia L, Pereira-Vaz J, Almeida S, Branquinho P, Côrte-Real R, Viseu R, Peres MJ, Sanches R, Dantas F, Freitas L, Andrade G, Maurílio M, Caldeira F, Cabral Veloso R, Mota-Vieira L, Soares M, Couto AR, Bruges-Armas J, Pinto RM, Sobrinho Simões J, Costa MDR, Guimarães JT, Martins L, Cunha M.

Vaccine. 2017 Apr 11;35(16):2092-2099. doi: 10.1016/j.vaccine.2017.02.019. Epub 2017 Mar 18.

PMID:
28318771
2.

Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.

Gaio V, Nunes B, Pechirra P, Conde P, Guiomar R, Dias CM, Barreto M.

PLoS One. 2016 Jun 28;11(6):e0158181. doi: 10.1371/journal.pone.0158181. eCollection 2016.

3.

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.

Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O; WHO European Region and the European Influenza Surveillance Network members of the reporting countries.

Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30184.

4.

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.

Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz IA, Bella A, Larrauri A, Ferenczi A; Joan O´Donell, Lazar M, Pechirra P, Korczyńska MR, Pozo F, Moren A; I-MOVE multicentre case-control team.

Euro Surveill. 2016;21(7):pii=30139. doi: 10.2807/1560-7917.ES.2016.21.7.30139. Erratum in: Euro Surveill. 2016;21(8). doi: 10.2807/1560-7917.ES.2016.21.8.30145.

5.

European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014.

Poelman R, Schuffenecker I, Van Leer-Buter C, Josset L, Niesters HG, Lina B; ESCV-ECDC EV-D68 study group.

J Clin Virol. 2015 Oct;71:1-9. doi: 10.1016/j.jcv.2015.07.296. Epub 2015 Jul 26.

6.

The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).

Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, Pitigoi D, Machado A, Pozo F; I-MOVE Multicentre Case Control Study Team.

Vaccine. 2015 Jun 4;33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012. Epub 2015 Apr 28.

7.

Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype.

Broberg E, Snacken R, Adlhoch C, Beauté J, Galinska M, Pereyaslov D, Brown C, Penttinen P; WHO European Region and the European Influenza Surveillance Network.

Euro Surveill. 2015 Jan 29;20(4). pii: 21023. No abstract available.

8.

Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries.

Beauté J, Zucs P, Korsun N, Bragstad K, Enouf V, Kossyvakis A, Griškevičius A, Olinger CM, Meijer A, Guiomar R, Prosenc K, Staroňová E, Delgado C, Brytting M, Broberg E; European Influenza Surveillance Network.

Epidemiol Infect. 2015 Oct;143(14):2950-8. doi: 10.1017/S0950268814003422. Epub 2015 Feb 4.

9.

Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.

Nunes B, Machado A, Guiomar R, Pechirra P, Conde P, Cristovão P, Falcão I.

Vaccine. 2014 Jul 31;32(35):4443-9. doi: 10.1016/j.vaccine.2014.06.053. Epub 2014 Jun 21.

PMID:
24962756
10.

Determination of French influenza outbreaks periods between 1985 and 2011 through a web-based Delphi method.

Debin M, Souty C, Turbelin C, Blanchon T, Boëlle PY, Hanslik T, Hejblum G, Le Strat Y, Quintus F; DelFluWeb Study Group, Falchi A.

BMC Med Inform Decis Mak. 2013 Dec 24;13:138. doi: 10.1186/1472-6947-13-138.

11.
12.

[National Influenza Surveillance Programme: results of influenza activity in Portugal in the 2010/2011 season].

Pechirra P, Gonçalves P, Conde P, Nunes B, Guiomar R.

Acta Med Port. 2012 Sep-Oct;25(5):277-87. Epub 2012 Nov 12. Portuguese.

13.

I-MOVE: a European network to measure the effectiveness of influenza vaccines.

Valenciano M, Ciancio B; I-MOVE study team.

Euro Surveill. 2012 Sep 27;17(39). pii: 20281.

14.

Contribution of the Portuguese Laboratory Network for the Diagnosis of Influenza A(H1N1)pdm09 infection during the 2009/10 and 2010/11 influenza seasons.

Portuguese Laboratory Network for the Diagnosis of Influenza Infection.

Euro Surveill. 2012 Jul 5;17(27). pii: 20211.

15.
16.

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, Stefanoff P, Nunes B, Pitigoi D, Larrauri A, Daviaud I, Horvath JK, O'Donnell J, Seyler T, Paradowska-Stankiewicz IA, Pechirra P, Ivanciuc AE, Jiménez-Jorge S, Savulescu C, Ciancio BC, Moren A.

PLoS One. 2011;6(11):e27622. doi: 10.1371/journal.pone.0027622. Epub 2011 Nov 15.

17.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.

Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.

18.

Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.

Kissling E, Valenciano M; I-MOVE case-control studies team.

Euro Surveill. 2011 Mar 17;16(11). pii: 19818.

19.

Heterogeneous selective pressure acting on influenza B Victoria- and Yamagata-like hemagglutinins.

Nunes B, Pechirra P, Coelho A, Ribeiro C, Arraiolos A, Rebelo-de-Andrade H.

J Mol Evol. 2008 Oct;67(4):427-35. doi: 10.1007/s00239-008-9154-9. Epub 2008 Oct 8.

PMID:
18841406
20.

Characterization of influenza A/Fujian/411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005.

Pechirra P, Gonçalves P, Arraiolos A, Coelho A, Rebelo-de-Andrade H.

J Med Virol. 2008 Sep;80(9):1624-30. doi: 10.1002/jmv.21258.

PMID:
18649331

Supplemental Content

Loading ...
Support Center